IL6 and Alzheimer disease: The present findings further support the involvement of IL-6-related pathways in AD pathogenesis, by suggesting that genetic predisposition to high circulating levels of IL-6 might trigger or potentiate AD-related neuropathological processes, perhaps through amplifying aging-related proinflammatory states and worsening the underlying immune dysregulation.